Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype

Blood

Volumn 101, Issue 10, 2003, Pages 3969-3976

  Oury, Cécile ^b   Kuijpers, Marijke J E ^b   Toth Zsamboki, Emese ^b   Bonnefoy, Arnaud ^b   Danloy, Sophie ^b   Vreys, Ingrid ^b   Feijge, Marion A H ^b   De Vos, Rita ^b   Vermylen, Jos ^b   Heemskerk, Johan W M ^b   Hoylaerts, Marc F ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; COLLAGEN; COLLAGEN FIBER; CONVULXIN; ION CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLSERINE; PURINE P2X RECEPTOR; PURINE P2 RECEPTOR; PURINE P2X1 RECEPTOR; THROMBIN;

ARTICLE; CELL LINEAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EVOKED RESPONSE; GENE OVEREXPRESSION; HUMAN; MALE; MEGAKARYOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; THROMBOCYTE RELEASE REACTION; THROMBOSIS; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; BLOOD CELL COUNT; CELL SIZE; CYTOLOGY; DRUG EFFECT; ERYTHROCYTE COUNT; GENETICS; KINETICS; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE COUNT; ULTRASTRUCTURE;

ADENOSINE DIPHOSPHATE; ANIMALS; BLOOD CELL COUNT; BLOOD PLATELETS; CELL SIZE; ERYTHROCYTE COUNT; HUMANS; ION CHANNELS; KINETICS; MEGAKARYOCYTES; MICE; MICE, TRANSGENIC; PHENOTYPE; PLATELET COUNT; RECEPTORS, PURINERGIC P2; THROMBIN; THROMBOSIS;

EID: 0037926895     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-10-3215     Document Type: Article

References (35)

1. Ravelic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413-492.
2. Abbracchio MP, Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther. 1994;64:445-475.
3. Buell G, Collo G, Rassendren F. P2X receptors: an emerging channel family. Eur J Neurosci. 1996;8:2221-2228.
4. Burnstock G. Potential therapeutic targets in the rapidly expanding field of purinergic signaling. Clin Med. 2002;2:45-53.
5. North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002;82:1013-1067.
6. Reimers HJ. Adenine nucleotides in blood platelets. In: Longenecker GL, ed. The Platelets: Physiology and Pharmacology. Orlando, FL: Academic Press; 1985:85-98.
7. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost. 2001;86:222-232.
8. 1 purinoceptors on rat platelets: effect of clopidogrel. Br J Haematol. 1997;98:880-886.
9. 1 not P2T purinoceptors in human platelets. J Biol Chem 1996;271:2879-2881.
10. 1 receptors; evidence for separate receptors stimulated by ATP and ADP on human platelets. Br J Pharmacol. 2000;131:108-114.
11. Evans RJ, Lewis C, Buell G, Valera S, North RA, Surprenant A. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol Pharmacol. 1995;48:178-183.
12. 1 purinoceptors with α,β-methylene ATP. Thromb Haemost. 2001;85:303-308.
13. 1 ion / channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost. 2001; 86:1264-1271.
14. 1-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen. Blood. 2002;100:2499-2505.
15. Denarler E, Martin F, Martineau S, Marguerie G. PCR cloning and sequence of the murine GPIIb gene promoter. Biochem Biophys Res Commun. 1993;195:1360-1364.
16. 1 receptor due to deletion of a single amino acid residue. J Biol Chem. 2000;275:22611-22614.
17. Tronick-Le Roux D, Roullot V, Schweitzer A, Berthier R, Marguerie G. Suppression of erythromegakaryocytopoiesis and the induction of reversible thrombocytopenia in mice transgenic for the thymidine kinase gene targeted by the platelet glycoprotein αIIb promoter. J Exp Med. 1995; 181:2141-2151.
18. Holvoet P, Danloy S, Collen D. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism: a study based on deletion and substitution variants in transgenic mice. Eur J Biochem. 1997;245:642-647.
19. Barnes CS, Krafft B, Frech M, et al. Production and characterization of saratin, an inhibitor of von Willebrand's factor-dependent platelet adhesion to collagen. Semin Thromb Hemost. 2001;27: 337-346.
20. 2+ entry by cAMP-dependent and cGMP-dependent protein kinases and phospholipase C in rat platelets. Eur J Biochem. 1994;223:543-551.
21. 2+ indicator dyes with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
22. 1 integrin is essential for platelet interaction with collagen. EMBO J. 2001;20:2120-2130.
23. 12 in platelet adhesion and thrombus formation in flowing blood. Arterioscler Thromb Vasc Biol. 2002;22:686-691.
24. 1 is required to inhibit platelet aggregation in whole blood under flow. Blood. 2001;98:3340-3345.
25. Ikeda Y, Handa M, Kawano K, et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 1991;87:1234-1240.
26. 2A receptors. J Biol Chem 1999;274:29108-29114.
27. Quinton TM, Ozdener F, Dangelmaier C, Daniel JL, Kunapuli SP. Glycoprotein VI-mediated platelet fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP. Blood. 2002;99:3228-3234.
28. Ikeda Y, Handa M, Kamata T, et al. Transmembrane calcium influx associated with von Willebrand factor binding to GPIb in the initiation of shear-induced platelet aggregation. Thromb Haemost. 1993;69:496-502.
29. 4 purinoceptors. Circ Res. 2000;87:385-391.
30. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94:657-666.
31. Heemskerk JWM, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002;88:186-193.
32. Coade SB, Pearson JD. Metabolism of adenine nucleotides in human blood. Circ Res. 1989;65: 531-537.
33. Enjyoji K, Sevigny J, Lin Y, et al. Targeted disruption of CD39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 1999;5:1010-1017.
34. 1 receptors. Nature. 2000; 403:86-89.
35. 1 knock-out mice [abstract]. J Hematol. 2002;87: 17.